Literature DB >> 8443903

Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.

W S Weintraub1, Z M Ghazzal, J S Douglas, H A Liberman, D C Morris, C L Cohen, S B King.   

Abstract

BACKGROUND: Restenosis remains a critical limitation after coronary angioplasty. There is little information comparing long-term prognosis in patients who suffer from restenosis and others who do not. The purpose of this paper is to determine the clinical events in patients with restenosis or continued patency documented by restudy coronary arteriography. METHODS AND
RESULTS: The source of data was the clinical data base at Emory University. Patients who had previous coronary surgery and patients who underwent angioplasty in the setting of acute myocardial infarction were excluded. A total of 3,363 patients undergoing angiographic restudy 4 months to 1 year after angioplasty were compared with 3,858 not undergoing restudy. In the restudy population, 1,570 had restenosis and 1,793 had patent arteries at all sites dilated. The restenosis patients were older and had more hypertension, more diabetes, more severe angina, more multivessel coronary artery disease, more severe stenoses, and less satisfactory original results. At restudy, in patients without restenosis, 38.7% had angina versus 70.7% in patients with restenosis (p < 0.0001). There were few deaths in the first 6 months. At 6 years, the survival rate was 0.95 without restenosis and 0.93 with restenosis (p = 0.16). At 6 months and 6 years, freedom from myocardial infarction was 0.97 and 0.88 without restenosis and 0.93 and 0.85 with restenosis (p = 0.0001). On multivariate analysis, restenosis was an independent correlate of myocardial infarction but not mortality. At 6 months and 6 years, freedom from coronary bypass surgery was 0.99 and 0.94 without restenosis and 0.91 and 0.78 with restenosis (p < 0.0001). At 6 months and 6 years, freedom from repeat angioplasty was 0.96 and 0.76 without restenosis and 0.44 and 0.20 with restenosis (p = 0.0001). The highest event rates were noted in the patients with restenosis with recurrent chest pain. Patients not undergoing restudy differed somewhat from the study group, and there were far fewer repeat revascularization procedures in the group not undergoing restudy.
CONCLUSIONS: Patients with restenosis are more likely to have recurrent angina pectoris. Although there is no or little difference in survival, there is a difference in myocardial infarction rate in the patients with and without restenosis. The low myocardial infarction and death rates in the group suffering restenosis may be related to repeat revascularization in these patients; the principal events in the restenosis population are frequent repeat revascularization procedures.

Entities:  

Mesh:

Year:  1993        PMID: 8443903     DOI: 10.1161/01.cir.87.3.831

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Plaque sealing by coronary angioplasty.

Authors:  B Meier
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

Review 2.  Drug eluting stents for ST-elevation myocardial infarction: risk and benefit.

Authors:  Jason Ryan; Donald E Cutlip; David J Cohen; Duane S Pinto
Journal:  J Thromb Thrombolysis       Date:  2007-05-05       Impact factor: 2.300

3.  Molecular atherectomy for restenosis.

Authors:  W Casscells; D A Lappi; A Baird
Journal:  Trends Cardiovasc Med       Date:  1993 Nov-Dec       Impact factor: 6.677

Review 4.  The perils of surrogate endpoints.

Authors:  William S Weintraub; Thomas F Lüscher; Stuart Pocock
Journal:  Eur Heart J       Date:  2015-05-13       Impact factor: 29.983

Review 5.  Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation.

Authors:  C J Dunn; R H Foster
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

Review 6.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

7.  Coronary artery disease in HIV infected patients.

Authors:  Lelia Escaut; Jean Jacques Monsuez; Gilles Chironi; Mansouriah Merad; Elina Teicher; Denis Smadja; Alain Simon; Daniel Vittecoq
Journal:  Intensive Care Med       Date:  2003-05-09       Impact factor: 17.440

8.  Ten-year mortality risk of patients undergoing elective PCI: long-term follow-up of the GENetic Determinants of Restenosis (GENDER) study : No increased mortality risk by restenosis, only by coronary artery disease itself.

Authors:  J J W Verschuren; S Trompet; R A Tio; R J de Winter; P A F M Doevendans; J W Jukema
Journal:  Neth Heart J       Date:  2013-02       Impact factor: 2.380

9.  A comparison of cardiovascular procedure use between the United States and Canada.

Authors:  D K Verrilli; R Berenson; S J Katz
Journal:  Health Serv Res       Date:  1998-08       Impact factor: 3.402

Review 10.  Abciximab. An updated review of its use in ischaemic heart disease.

Authors:  R H Foster; L R Wiseman
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.